国家组织药品集中采购和使用试点扩围江西中选结果25个药品自2019年12月20日起在全省执行，第二批国家组织药品集中采购和使用江西中选结果32个药品自2020年4月11日起在全省执行。现将截至2020年5月31日采购进度及有关情况通报如下。
一、扩围中选品种采购情况
（一）采购数量。25个药品的31个品规在全省12个联盟地区采购总数量为24861.03万片/支/袋。按药品统计，最高为厄贝沙坦75mg的4052.56万片，最低为培美曲塞500mg的2103支。
（二）采购金额。31个品规的全省采购总金额为21786.06万元，占同品规药品采购金额的55.41%。按药品统计，最高为氯吡格雷75mg的4706.3万元，最低为赖诺普利10mg的8.51万元。
（三）完成进度。31个品规的全省采购总数量占约定采购总量的比例为118.56%，21个品规完成全省约定采购数量，6个品规完成75%，4个品规完成50%。按药品统计，完成进度最高的为左乙拉西坦250mg的569.24%，最低的为培美曲塞500mg的55.34%。
（四）中选药占比。31个品规的全省采购总数量占同品规下所有药品采购总数量的比例为86.54%。按药品统计，最高为培美曲塞100mg的98.58%，最低为阿托伐他汀20mg的74.11%。
（五）网上配送率。31个品规的全省采购订单总数量为35366.70万片/支/袋，企业网上配送数量为26416.68万片，配送率为74.69%。按药品统计，有3个品规的配送率低于60%，分别为瑞舒伐他汀5mg的44.48%、替诺福韦300mg的47.75%和瑞舒伐他汀10mg的53.48%。
二、第二批中选品种采购情况
（一）采购数量。32个药品的36个品规在全省12个联盟地区采购总数量为7196.06万片/支/袋。按药品统计，最高为阿卡波糖50mg的2997.87万片，最低为安立生坦片5mg的1950片。
（二）采购金额。36个品规的全省采购总金额为2603.55万元，占同品规药品采购金额的58.03%。按药品统计，最高为阿卡波糖50mg的541.53万元，最低为比索洛尔2.5mg的0.26万元。
（三）完成进度。36个品规的全省采购总数量占约定采购总量的比例为57.08%，4个品规完成全省约定采购数量，11个品规完成进度大于50%。按药品统计，最高为阿比特龙0.25g的696.92%，最低为比索洛尔2.5mg的1.99%。
（四）中选药占比。36个品规的全省采购总数量占同品规下所有药品采购总数量的比例为84.88%；按药品统计，最高为安立生坦片5mg的100%，最低为阿莫西林0.5g的25.41%。
（五）网上配送率。36个品规的全省采购订单总数量为9201.17万片/支/袋，企业网上配送数量为7464.93万片/支/袋，配送率为81.13%。有6个品规的配送率低于70%，分别是比索洛尔2.5mg的9.45%、奥美沙坦酯20mg的28.56%、曲美他35mg的34.64%、阿莫西林0.5g的35.6%、美洛昔康7.5mg的44.89%和格列美脲2mg的45.06%。
三、中选品种回款情况
截至5月底,采购平台共有各供货企业和医疗机构的明细账单27565份，两批次国家带量采购中选药品在全省12个采购联盟的网上采购总金额为24389.6万元，回款（含预付）总金额为22583.9万元，回款比例为92.6%。
附表1:国家组织药品集中采购和使用试点扩围江西中选药品采购情况（截至5月31日）
| 药品 | 采购数量 （万片/支/袋） | 采购金额 （万元） | 完成进度 | 中选药占比 | 网上配送率 |
| 阿托伐他汀10mg | 1762.56 | 211.51 | 144.25% | 89.58% | 70.41% |
| 阿托伐他汀20mg | 2354.69 | 481.03 | 125.17% | 74.11% | 67.11% |
| 瑞舒伐他汀10mg | 1826.76 | 416.50 | 182.40% | 86.84% | 53.48% |
| 瑞舒伐他汀5mg | 628.04 | 82.17 | 133.60% | 83.95% | 44.48% |
| 氯吡格雷75mg | 1849.76 | 4706.31 | 139.54% | 95.27% | 92.25% |
| 厄贝沙坦75mg | 4052.56 | 785.44 | 89.85% | 96.79% | 87.87% |
| 氨氯地平5mg | 3844.95 | 230.70 | 132.59% | 79.36% | 71.80% |
| 恩替卡韦0.5mg | 2222.73 | 610.46 | 109.90% | 86.14% | 73.41% |
| 艾司西酞普兰10mg | 179.34 | 757.22 | 147.19% | 77.99% | 92.66% |
| 帕罗西汀20mg | 185.78 | 289.48 | 107.28% | 89.93% | 93.79% |
| 奥氮平10mg | 248.34 | 1546.82 | 88.76% | 91.27% | 99.63% |
| 奥氮平5mg | 310.63 | 1109.61 | 135.96% | 88.27% | 97.71% |
| 头孢呋辛250mg | 356.32 | 172.37 | 68.31% | 94.89% | 94.08% |
| 利培酮1mg | 1303.21 | 156.39 | 80.69% | 87.45% | 82.74% |
| 吉非替尼250mg | 7.02 | 383.72 | 63.03% | 90.39% | 93.82% |
| 福辛普利10mg | 41.66 | 34.26 | 58.01% | 96.45% | 81.45% |
| 厄贝沙坦氢氯噻嗪150mg+12.5mg | 684.06 | 697.74 | 130.75% | 88.28% | 94.12% |
| 赖诺普利10mg | 36.95 | 8.51 | 178.31% | 93.71% | 83.41% |
| 替诺福韦300mg | 179.34 | 67.97 | 206.80% | 75.01% | 47.75% |
| 氯沙坦100mg | 44.01 | 78.90 | 194.29% | 93.81% | 79.09% |
| 氯沙坦50mg | 1015.44 | 1041.33 | 239.12% | 91.98% | 88.42% |
| 依那普利10mg | 715.90 | 399.56 | 138.18% | 91.71% | 92.25% |
| 依那普利5mg | 419.09 | 137.52 | 89.90% | 78.06% | 93.14% |
| 左乙拉西坦250mg | 112.65 | 269.58 | 569.24% | 93.68% | 95.08% |
| 伊马替尼100mg | 18.48 | 192.04 | 294.72% | 95.89% | 97.37% |
| 孟鲁司特10mg | 140.70 | 545.33 | 102.71% | 83.60% | 97.81% |
| 蒙脱石3g | 249.78 | 82.22 | 75.26% | 86.49% | 93.17% |
| 培美曲塞100mg | 0.6592 | 526.04 | 115.65% | 98.58% | 100.00% |
| 培美曲塞500mg | 0.2103 | 575.35 | 55.34% | 95.90% | 99.53% |
| 氟比洛芬酯50mg/5ml | 36.42 | 799.41 | 86.82% | 80.92% | 94.73% |
| 右美托咪定0.2mg/2ml | 33.01 | 4390.60 | 241.67% | 94.32% | 98.78% |
| 总计 | 24861.03 | 21786.06 | 118.56% | 86.54% | 74.69% |
附表2:第二批国家组织药品集中采购江西中选药品采购情况（截至5月31日）
| 药品 | 采购数量 （万片/支/袋） | 采购金额 （万元） | 完成进度 | 中选药占比 | 网上配送率 |
| 阿比特龙口服常释剂型0.25g | 5.44 | 194.61 | 696.92% | 99.12% | 85.31% |
| 阿德福韦酯口服常释剂型10mg | 110.47 | 99.42 | 200.31% | 89.95% | 87.76% |
| 阿卡波糖口服常释剂型50mg | 2997.87 | 541.53 | 66.62% | 86.09% | 87.33% |
| 阿卡波糖口服常释剂型100mg | 55.61 | 17.07 | 26.97% | 90.09% | 72.01% |
| 阿莫西林口服常释剂型0.25g | 802.43 | 53.36 | 64.92% | 78.84% | 97.44% |
| 阿莫西林口服常释剂型0.5g | 25.28 | 2.91 | 3.76% | 25.41% | 35.60% |
| 阿奇霉素口服常释剂型0.25g | 44.43 | 47.09 | 18.21% | 66.48% | 99.58% |
| 安立生坦片5mg | 0.20 | 3.90 | 92.86% | 100.00% | 91.30% |
| 奥美沙坦酯口服常释剂型20mg | 13.82 | 8.43 | 33.48% | 74.82% | 28.56% |
| 比索洛尔口服常释剂型2.5mg | 0.70 | 0.26 | 1.99% | 24.60% | 9.45% |
| 比索洛尔口服常释剂型5mg | 83.69 | 53.06 | 43.29% | 73.32% | 97.38% |
| 对乙酰氨基酚口服常释剂型0.5g | 45.58 | 2.55 | 60.31% | 93.65% | 89.50% |
| 多奈哌齐口服常释剂型5mg | 19.24 | 21.87 | 46.86% | 83.24% | 80.57% |
| 氟康唑口服常释剂型50mg | 28.15 | 7.93 | 26.07% | 81.64% | 97.14% |
| 福多司坦口服常释剂型0.2g | 115.74 | 73.21 | 32.83% | 86.56% | 85.93% |
| 格列美脲口服常释剂型2mg | 508.72 | 39.34 | 46.70% | 88.04% | 45.06% |
| 甲硝唑口服常释剂型0.2g | 418.55 | 21.22 | 69.11% | 88.07% | 96.88% |
| 聚乙二醇口服散剂10g | 19.43 | 22.97 | 82.38% | 98.74% | 76.16% |
| 坎地沙坦酯口服常释剂型4mg | 201.09 | 54.58 | 26.30% | 85.25% | 99.69% |
| 克林霉素口服常释剂型0.15g | 19.63 | 1.96 | 34.64% | 70.23% | 99.51% |
| 铝碳酸镁咀嚼片0.5g | 113.46 | 29.50 | 75.08% | 93.71% | 98.75% |
| 美洛昔康口服常释剂型7.5mg | 30.33 | 8.14 | 46.11% | 79.32% | 43.21% |
| 莫西沙星口服常释剂型0.4g | 9.31 | 20.58 | 44.32% | 84.10% | 74.65% |
| 曲美他嗪缓释控释剂型35mg | 91.46 | 42.80 | 64.03% | 93.68% | 34.64% |
| 索利那新口服常释剂型5mg | 1.56 | 5.16 | 45.26% | 86.21% | 88.93% |
| 他达拉非片20mg | 0.54 | 25.59 | 59.13% | 86.27% | 97.06% |
| 特拉唑嗪口服常释剂型2mg | 70.95 | 34.31 | 49.38% | 84.41% | 95.00% |
| 替吉奥口服常释剂型20mg | 25.37 | 198.07 | 26.60% | 90.01% | 99.04% |
| 替吉奥口服常释剂型25mg | 18.10 | 167.68 | 43.93% | 84.76% | 98.62% |
| 头孢氨苄口服常释剂型0.25g | 79.71 | 6.79 | 46.73% | 84.52% | 83.86% |
| 头孢拉定口服常释剂型0.25g | 162.43 | 19.38 | 72.06% | 79.89% | 96.05% |
| 辛伐他汀口服常释剂型20mg | 700.44 | 74.05 | 101.20% | 90.63% | 94.42% |
| 异烟肼口服常释剂型0.1g | 271.10 | 10.79 | 86.78% | 85.82% | 89.85% |
| 吲达帕胺口服常释剂型2.5mg | 70.32 | 4.89 | 42.74% | 94.03% | 95.10% |
| 紫杉醇（白蛋白结合型）100mg | 0.87 | 678.76 | 106.84% | 95.37% | 96.98% |
| 左西替利嗪口服常释剂型5mg | 34.02 | 9.78 | 46.04% | 79.46% | 95.37% |
| 总计 | 7196.06 | 2603.55 | 57.08% | 84.88% | 81.13% |